70.
Müller F. “Flavin Radicals: Chemistry and Biochemistry.” Free Radical Biology and
Medicine. Vol. 3, no. 3. (1987): 215–30.
71.
Garber K. “Biochemistry: A Radical Treatment.” Nature. Vol. 489. (2012) S4–6.
72.
Mathew ST, Bergström P, Hammarsten O. “Repeated Nrf2 Stimulation Using Sulforaphane
Protects Fibroblasts from Ionizing Radiation.” Toxicology and Applied Pharmacology. Vol.
276, no. 3. (May 2014): 188–194.
73.
Reisman SA, Lee CY, Meyer CJ, Proksch JW, Sonis ST, Ward KW. “Topical Application of the
Synthetic Triterpenoid RTA 408 Protects Mice from Radiation-Induced Dermatitis.”
Radiation Research. Vol. 181, no. 5. (May 2014): 512–520.
74.
Iranshahy M, Iranshahi M, Abtahi SR, Karimi G. “The Role of Nuclear Factor Erythroid 2-
Related Factor 2 in Hepatoprotective Activity of Natural Products: A Review.” Food and
Chemical Toxicology. Vol. 120. (October 2018): 261–276. doi: 10.1016/j.fct.2018.07.024.
75.
O’Connell MA, Hayes JD. “The Keap1/Nrf2 Pathway in Health and Disease: From the Bench
to the Clinic.” Biochemical Society Transactions. Vol. 43. (2015): 687–689.
76.
Marik PE, Khangoora V, Rivera R, Hooper MH, Catravas J. “Hydrocortisone, Vitamin C, and
Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-
After
Study.”
Chest.
Vol.
151,
no.
6.
(June
2017):
1229–1238.
doi:
10.1016/j.chest.2016.11.036.
77.
Hershey TB, Kahn JM. “State Sepsis Mandates—A New Era for Regulation of Hospital
Quality.” New England Journal oƒ Medicine. Vol. 376, no. 24. (June 15, 2017): 2311–2313.
doi: 10.1056/NEJMp1611928.
78.
Shin TG, Kim YJ, Ryoo SM, Hwang SY, Jo IJ, Chung SP, Choi SH, Suh GJ, Kim WY. “Early
Vitamin C and Thiamine Administration to Patients with Septic Shock in Emergency
Departments: Propensity Score-Based Analysis of a Before-and-After Cohort Study.”
Journal oƒ Clinical Medicine. Vol. 8, no. 1. (January 16, 2019): E102. doi:
10.3390/jcm8010102.
79.
Balakrishnan M, Gandhi H, Shah K, Pandya H, Patel R, Keshwani S, Yadav N.
“Hydrocortisone, Vitamin C and Thiamine for the Treatment of Sepsis and Septic Shock
Following Cardiac Surgery.” Indian Journal oƒ Anaesthesia. Vol. 62, no. 12. (December
2018): 934-939. doi: 10.4103/ija.IJA_361_18.
80.
Marik PE. “Hydrocortisone, Ascorbic Acid and Thiamine (HAT Therapy) for the Treatment of
Sepsis. Focus on Ascorbic Acid.” Nutrients. Vol. 10, no. 11. (November 14, 2018): E1762.
doi: 10.3390/nu10111762.
81.
Moskowitz A, Andersen LW, Huang DT, Berg KM, Grossestreuer AV, Marik PE, Sherwin RL,
Hou PC, Becker LB, Cocchi MN, Doshi P, Gong J, Sen A, Donnino MW. “Ascorbic Acid,
Corticosteroids, and Thiamine in Sepsis: A Review of the Biologic Rationale and the Present
State of Clinical Evaluation.” Critical Care. Vol. 22, no. 1. (October 29, 2018): 283. doi:
10.1186/s13054-018-2217-4.
82.
Surh YJ, Kundu JK, Na HK. “Nrf2 as a Master Redox Switch in Turning on the Cellular
Signaling Involved in the Induction of Cytoprotective Genes by Some Chemopreventive
Phytochemicals.” Planta Medica. Vol. 74, no. 13. (October 2008): 1526–39.
83.
Nakagawa F, Morino K, Ugi S, Ishikado A, Kondo K, Sato D, Konno S, Nemoto K, Kusunoki
C, Sekine O, Sunagawa A, Kawamura M, Inoue N, Nishio Y, Maegawa H. “4-Hydroxy
